Britain is backing stem cell research with new international links and domestic projects within an EU still willing to fund certain types of research. And the British Prime Minister, Tony Blair, used his trip to California last month to back the field in spite of sharp opposition from President George Bush, who used his first presidential veto to block federal funding for human embryonic stem cell research just days earlier.
Blair met with the state governor, Arnold Schwarzenegger. who also backs stem cell research, along with staff from 10 bioscience companies based in the San Francisco area, and unveiled plans for a joint UKCalifornia conference on stem cell technology in Britain in November. California has pledged state funds in an initiative supported by voters, although this is presently under challenge in the courts.
While eggs for cloning and stem cell work. As a result of a new ruling, women undergoing in vitro fertilisation (IVF) treatment will be able to halve the cost of the expensive procedure under the new ruling which allows them to sell some of their eggs for use in stem cell research. Scientists at Newcastle University, who created the world's first cloned human embryo last year, were last month granted a licence for 'egg sharing' by the Human Fertilisation and Embryology Authority.
Egg-sharing has been in operation at IVF centres for 10 years, but scientists from Newcastle and Durham universities are the first to be granted permission to extend the system so that it provides eggs for research. The new scheme involves the research team, from the North East England Stem Cell Institute (NESCI), paying half the cost of an egg donor's IVF treatment in return for a donation of up to half the eggs produced for research.
Until now, researchers investigating stem cells and therapeutic cloning have generally had to make do with surplus unfertilised eggs from IVF clinics. But this generates only a highly restricted supply of poor-quality eggs. For the best chance of success, scientists know they must have a good source of fresh eggs, rather than 'failed' clinic rejects.
It is hoped that donors will be recruited at the rate of one a week. Each is expected to provide the researchers with between six and ten fresh eggs. The team believes the scheme, which still needs to be funded and is not expected to come into operation until next year, will speed up progress towards developing stem cell treatments.
Alison Murdoch, whose team at NESCI has been granted the licence, said that paying women would not make any difference to their treatment. "It won't put the women at any increased risk because they are going to have exactly the same treatment that they are going to have for IVF anyway," she said, adding that it would enable more women to afford treatment.
But critics worry that the dual purpose of the treatment will create a potential conflict of interest for doctors. For example, donors might be given an inappropriately high dose of drugs used to stimulate the ovary so that more eggs can be extracted. "It's pulling the clinicians in two different ways," says Donna Dickenson, at Birkbeck College, London, who sits on the ethics committee of the Royal College of Obstetricians and Gynaecologists. "The primary objective has got to be to treat the individual patient, but if there is also a desire to harvest extra [eggs]… I think there could be two conflicting objectives," she said.
Last year, Murdoch's team was granted approval by the HFEA to ask IVF patients to donate, without payment, two eggs to research if more than 12 eggs had been collected for their treatment. But in seven months they were able to collect only 66 eggs, which were available unpredictably.
The HFEA also unveiled a public consultation on egg donation for research by women not undergoing IVF. This is more controversial, because it involves the donor taking hormonal drugs which stop the menstrual cycle and then over-stimulate the ovary to release more eggs than usual.
Such donations are currently only permitted to women undergoing fertility treatment. Dickenson said there were risks to donors from hormonal drugs, and the longer term risks were not yet known.
The new moves in stem cell research in Britain came as an EU council meeting agreed last month that research should still be funded on the use of human embryonic stem cells as long as it did not involve the destruction of embryos for the harvesting of stem cell lines. The decision follows intense lobbying from some groups to stop the EU's funding for stem cell research altogether. The Vatican is vociferously opposed to research involving stem cells and its newspaper, L'Osservatore Romano, termed the agreement 'the macabre product of a twisted sense of progress'.
But the British science minister, Lord Sainsbury, welcomed the decision. "In Europe we are moving forward on this front, whereas America has taken, as far as the federal government is concerned, a very negative position. That Europe is moving forward is extremely good."
